This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1967 Feb;29(2):136-49.

doi: 10.1111/j.1476-5381.1967.tb01947.x.

Kinetic considerations relating to the accrual and elimination of drug metabolites

A J Cummings, B K Martin, G S Park

PMID: 6032052
PMCID: PMC1557201
DOI: 10.1111/j.1476-5381.1967.tb01947.x

Kinetic considerations relating to the accrual and elimination of drug metabolites

A J Cummings et al. Br J Pharmacol Chemother. 1967 Feb.

. 1967 Feb;29(2):136-49.

doi: 10.1111/j.1476-5381.1967.tb01947.x.

Authors

A J Cummings, B K Martin, G S Park

PMID: 6032052
PMCID: PMC1557201
DOI: 10.1111/j.1476-5381.1967.tb01947.x

No abstract available

PubMed Disclaimer

Similar articles

Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE. Schumacher GE. Am J Hosp Pharm. 1972 Apr;29(4):339-43. Am J Hosp Pharm. 1972. PMID: 5025265 No abstract available.
Kinetic considerations relating to the use of drug precursors.
Martin BK. Martin BK. Br J Pharmacol Chemother. 1967 Nov;31(3):420-34. doi: 10.1111/j.1476-5381.1967.tb00409.x. Br J Pharmacol Chemother. 1967. PMID: 6083115 Free PMC article. No abstract available.
Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
Gillette JR. Gillette JR. Drug Metab Rev. 1979;10(1):59-87. doi: 10.3109/03602537908993901. Drug Metab Rev. 1979. PMID: 118860 Review.
[Problems of pharmacokinetics].
Gillmann H. Gillmann H. Arzneimittelforschung. 1972 Feb;22(2):283-5. Arzneimittelforschung. 1972. PMID: 5067477 German. No abstract available.
The significance of drugs in breast milk. Pharmacokinetic considerations.
Rivera-Calimlim L. Rivera-Calimlim L. Clin Perinatol. 1987 Mar;14(1):51-70. Clin Perinatol. 1987. PMID: 3549115 Review.

See all similar articles

Cited by

Pharmacokinetics of isoniazid metabolism in man.
Ellard GA, Gammon PT. Ellard GA, et al. J Pharmacokinet Biopharm. 1976 Apr;4(2):83-113. doi: 10.1007/BF01086149. J Pharmacokinet Biopharm. 1976. PMID: 950592 No abstract available.
Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.
Soine WH, Soine PJ, Wireko FC, Abraham DJ. Soine WH, et al. Pharm Res. 1990 Aug;7(8):794-800. doi: 10.1023/a:1015900629690. Pharm Res. 1990. PMID: 2235876
Drug urinary excretion data--some aspects concerning the interpretation.
Martin BK. Martin BK. Br J Pharmacol Chemother. 1967 Feb;29(2):181-93. doi: 10.1111/j.1476-5381.1967.tb01951.x. Br J Pharmacol Chemother. 1967. PMID: 6032054 Free PMC article. No abstract available.
Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.
Pang KS. Pang KS. J Pharmacokinet Biopharm. 1981 Aug;9(4):477-87. doi: 10.1007/BF01060890. J Pharmacokinet Biopharm. 1981. PMID: 7310645
The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.
Wilson K, Burnett D, Oram M, Reynolds CT. Wilson K, et al. Eur J Drug Metab Pharmacokinet. 1981;6(4):289-95. doi: 10.1007/BF03189528. Eur J Drug Metab Pharmacokinet. 1981. PMID: 7333329

See all "Cited by" articles

References

1. Biochem J. 1951 Jan;48(1):88-96 - PubMed
1. Nature. 1957 Jan 12;179(4550):98-100 - PubMed
1. Nature. 1963 Dec 28;200:1296-7 - PubMed

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources